A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer
- 14 September 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 109 (2), 458-463
- https://doi.org/10.1016/j.ijrobp.2020.09.010
Abstract
No abstract availableFunding Information
- Merck
- EMD Serono
This publication has 11 references indexed in Scilit:
- Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC TrialJournal of Clinical Oncology, 2020
- Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice GuidelinePractical Radiation Oncology, 2019
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThe New England Journal of Medicine, 2018
- Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical TrialJAMA Oncology, 2018
- A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreatic Ductal AdenocarcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2014
- Mapping Patterns of Local Recurrence After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A New Approach to Adjuvant Radiation Field DesignInternational Journal of Radiation Oncology*Biology*Physics, 2013
- Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease ProgressionJournal of Clinical Oncology, 2011
- Phase I Study of Preoperative Short-Course Chemoradiation With Proton Beam Therapy and Capecitabine for Resectable Pancreatic Ductal Adenocarcinoma of the HeadInternational Journal of Radiation Oncology*Biology*Physics, 2011
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic CancerJournal of Clinical Oncology, 2009
- One Thousand Consecutive PancreaticoduodenectomiesAnnals of Surgery, 2006